Skip to main content
FERMENTA BIOTECH LIMITED logo

FERMENTA BIOTECH LIMITED — Investor Relations & Filings

Ticker · FERMENTA ISIN · INE225B01021 LEI · 335800VNTNWW8G1U9314 BSE.NS Manufacturing
Open in API
Filings indexed 671 across all filing types
Latest filing 2020-01-28 Regulatory Filings
Country IN India
Listing BSE.NS FERMENTA

About FERMENTA BIOTECH LIMITED

https://fermentabiotech.com

Fermenta Biotech Limited is a specialized biotechnology company primarily focused on the development and manufacture of Vitamin D3 (Cholecalciferol). As one of the few vertically integrated manufacturers globally, the company produces Vitamin D3 for diverse applications, including pharmaceuticals, dietary supplements, human nutrition, and animal feed. Beyond its core Vitamin D3 portfolio, the company offers a range of specialty enzymes, particularly for the synthesis of beta-lactam antibiotics, and provides environmental solutions through its biotechnology expertise. Fermenta Biotech emphasizes high-quality standards, maintaining various international certifications for its manufacturing facilities. Its product offerings extend to premixes and value-added formats designed to meet specific formulation requirements. The company serves a global clientele, leveraging its research and development capabilities to innovate in the fields of nutrition and biotechnology.

Recent filings

Filing Released Lang Actions
(A) Voting Results of postal ballot including e-voting Pursuant to Regulation 44(3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, ....
Regulatory Filings
2020-01-28 English
(A) Voting Results of postal ballot including e-voting Pursuant to Regulation 44(3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, ....
Regulatory Filings
2020-01-28 English
Intimation of Schedule of Analysts / Institutional Investors meeting under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 Pursuant to the relevant provisions ....
Investor Presentation Classification · 95% confidence The document is a formal letter addressed to the stock exchange (BSE Limited) informing about a scheduled meeting with analysts and institutional investors. It references SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and mentions that an Investor Presentation for December 2019 will be shared during the interaction and is available on the BSE website. The document does not contain the presentation itself or detailed financial data but serves as an announcement of the upcoming investor meeting and the availability of the presentation. The document length is short (1856 characters), and it is primarily an announcement rather than the report or presentation itself. Therefore, it fits best under the category of Investor Presentation (IP) as it relates to investor communication and presentation scheduling.
2020-01-28 English
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we inform you that the Company has received information from Link Intime India ....
Regulatory Filings Classification · 95% confidence The document is an intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding the loss of share certificates. It is addressed to the stock exchange and provides details about the lost certificates. This type of filing is a notification related to shareholding and share certificates but does not report financial results, management changes, or other report types. It is a regulatory announcement about share certificates lost by holders, which fits best under Regulatory Filings (RNS) as it does not match other more specific categories like Major Shareholding Notification or Director's Dealing. The document length is short and it is an official regulatory communication.
2020-01-24 English
Pursuant to the provisions of Regulation 74(5) of SEBI (Depositories and Participants), Regulations 2018, for the quarter ended December 31, 2019, we hereby certify that within 15 days ....
Regulatory Filings
2020-01-17 English
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we inform you that the Company has received information from Link Intime India ....
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to the stock exchange (BSE Limited) under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It informs about the loss of share certificates and provides details such as folio number, certificate number, and number of shares lost. This is a regulatory disclosure related to share certificates but does not contain financial data, management discussion, or report content. It is an announcement of a specific event related to shareholding records, not a financial report or management information. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-01-15 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.